This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Apr;2(4):288-90.

doi: 10.1158/1940-6207.CAPR-09-0033. Epub 2009 Mar 31.

Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects: the plot thickens

Lawrence J Marnett¹

Affiliations

Affiliation

¹ Department of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. larry.marnett@vanderbilt.edu

PMID: 19336721
DOI: 10.1158/1940-6207.CAPR-09-0033

Review

Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects: the plot thickens

Lawrence J Marnett. Cancer Prev Res (Phila). 2009 Apr.

. 2009 Apr;2(4):288-90.

doi: 10.1158/1940-6207.CAPR-09-0033. Epub 2009 Mar 31.

Author

Lawrence J Marnett¹

Affiliation

¹ Department of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. larry.marnett@vanderbilt.edu

PMID: 19336721
DOI: 10.1158/1940-6207.CAPR-09-0033

No abstract available

PubMed Disclaimer

Comment on

Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.
Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, Newman RA, Morrow JD, Milne GL, Dannenberg AJ. Duffield-Lillico AJ, et al. Cancer Prev Res (Phila). 2009 Apr;2(4):322-9. doi: 10.1158/1940-6207.CAPR-09-0005. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336727 Free PMC article. Clinical Trial.

Similar articles

[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
Guo ZR. Guo ZR. Yao Xue Xue Bao. 2005 Nov;40(11):967-9. Yao Xue Xue Bao. 2005. PMID: 16499077 Review. Chinese. No abstract available.
Physiology. COX-2 inhibitors and cardiovascular risk.
Cannon CP, Cannon PJ. Cannon CP, et al. Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398. Science. 2012. PMID: 22700906 No abstract available.
Coxibs and heart disease: what we have learned and what else we need to know.
Zarraga IG, Schwarz ER. Zarraga IG, et al. J Am Coll Cardiol. 2007 Jan 2;49(1):1-14. doi: 10.1016/j.jacc.2006.10.003. Epub 2006 Dec 13. J Am Coll Cardiol. 2007. PMID: 17207715 Review.
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.
Crofford LJ, Breyer MD, Strand CV, Rushitzka F, Brune K, Farkouh ME, Simon LS. Crofford LJ, et al. J Rheumatol. 2006 Jul;33(7):1403-8. Epub 2006 May 15. J Rheumatol. 2006. PMID: 16724374
Cardiovascular risks of cyclooxygenase inhibition.
Stacy ZA, Dobesh PP, Trujillo TC. Stacy ZA, et al. Pharmacotherapy. 2006 Jul;26(7):919-38. doi: 10.1592/phco.26.7.919. Pharmacotherapy. 2006. PMID: 16803424 Review.

See all similar articles

Cited by

Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.
Qandil AM. Qandil AM. Int J Mol Sci. 2012 Dec 17;13(12):17244-74. doi: 10.3390/ijms131217244. Int J Mol Sci. 2012. PMID: 23247285 Free PMC article. Review.
Synergy of Physico-chemical and Biological Experiments for Developing a Cyclooxygenase-2 Inhibitor.
Singh P, Kaur J, Kaur H, Kaur A, Bhatti R. Singh P, et al. Sci Rep. 2018 Jul 3;8(1):10005. doi: 10.1038/s41598-018-28408-8. Sci Rep. 2018. PMID: 29968808 Free PMC article.
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.
Mohebati A, Milne GL, Zhou XK, Duffield-Lillico AJ, Boyle JO, Knutson A, Bosworth BP, Kingsley PJ, Marnett LJ, Brown PH, Akpa EG, Szabo E, Dannenberg AJ. Mohebati A, et al. Cancer Prev Res (Phila). 2013 Jul;6(7):646-55. doi: 10.1158/1940-6207.CAPR-13-0083. Epub 2013 May 16. Cancer Prev Res (Phila). 2013. PMID: 23682075 Free PMC article. Clinical Trial.
Epithelium-dependent modulation of responsiveness of airways from caveolin-1 knockout mice is mediated through cyclooxygenase-2 and 5-lipoxygenase.
Sharma P, Ryu MH, Basu S, Maltby SA, Yeganeh B, Mutawe MM, Mitchell RW, Halayko AJ. Sharma P, et al. Br J Pharmacol. 2012 Oct;167(3):548-60. doi: 10.1111/j.1476-5381.2012.02014.x. Br J Pharmacol. 2012. PMID: 22551156 Free PMC article.
Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP.
Almendingen K, Larsen LN, Fausa O, Bratlie J, Høstmark AT, Aabakken L. Almendingen K, et al. Fam Cancer. 2010 Dec;9(4):571-80. doi: 10.1007/s10689-010-9365-2. Fam Cancer. 2010. PMID: 20593240 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Research Materials
- NCI CPTC Antibody Characterization Program